ArticleFrontiers in pharmacology2020

Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System.

Tao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.